Search
for
Sort by
Research 691–720 of 1000+
- Alopecia Areata: A tissue specific autoimmune disease of the hair follicle
- Lichen Planopilaris: Update on Diagnosis and Treatment
- Gender differences in skin: A review of the literature
- Alopecia areata
- Clinical manifestations of cutaneous lupus erythematosus
- Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection
- Exosomes for repair, regeneration and rejuvenation
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Probiotic Bacteria Induce a ‘Glow of Health’
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- Dermal Adipocyte Lipolysis and Myofibroblast Conversion Are Required for Efficient Skin Repair
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- HAIR REGROWTH
- Drug-Induced Skin, Nail and Hair Disorders
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Interferon in the treatment of cutaneous T-cell lymphoma
- Skin biopsy
- Cutaneous reactions to recombinant cytokine therapy
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53
- Delivery and targeting of nanoparticles into hair follicles
- THE PATHOGENESIS OF ALOPECIA AREATA
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Epidermal Notch1 recruits RORγ+ group 3 innate lymphoid cells to orchestrate normal skin repair
- Green tea: Health benefits
- Alopecia Areata Update
- Ritlecitinib: First Approval
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis